Sol-Gel Technologies Ltd (SLGL)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Alon Seri-Levy |
| Employees: | 50 |
| Web site: | sol-gel.com |
|
7 GOLDA MEIR ST., WEIZMANN SCIENCE PARK, NESS ZIONA, L3, 7403648
97289313433
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Sol-Gel Technologies Ltd. focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system. Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris, Epsolay, SGT-210, and Erlotinib, Tapinarof, and roflumilast are the company's lead product candidates.
Please log in first to see chart